SEC Form 4 · accession 0001250853-16-000149
IOVANCE BIOTHERAPEUTICS, INC. · IOVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven A. Fischkoff
Officer — Chief Medical Officer
Period of report
Feb 4, 2016
Accepted (ET)
Apr 21, 2016 · 1:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001425205
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $5.43 | Feb 4, 2016 | A | 225,000 | A | — | Feb 4, 2026 | Common Stock | 225,000 | 225,000 | D |
Explanation of responses
- F1The option will vest as to 75,000 shares on February 4, 2017, and the remaining options shall vest as to 18,750 shares quarterly over the next two years after February 4, 2017, provided the Reporting Person is still providing services to the Issuer on the respective dates.